Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

R.B. Walter, M. Othus, B. Lowenberg, G.J. Ossenkoppele, S.H. Petersdorf, T. Pabst, M.C. Vekemans, F.R. Appelbaum, H.P. Erba, E.H. Estey

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)E409-E411
JournalHaematologica
Volume100
Issue number10
DOIs
Publication statusPublished - 2015

Cite this